Paul K. Legaard is a registered patent attorney who concentrates his practice on all aspects of intellectual property. Paul’s practice includes intellectual property matters for Fortune 500 companies, midsize pharmaceutical and biotechnology companies, startup companies and venture capital groups, as well as for nonprofit companies, academic institutions and research institutes.
Paul’s practice focuses on the pharmaceutical, biotechnology, diagnostics, genetics, vaccines, immunobiology, small molecule chemistry, polymer chemistry, oligonucleotide chemistry, nutraceutical, nanotechnology, biomedical device, scientific instrumentation, and food and beverage industries.
Areas of Paul’s comprehensive expertise includes:
- transactional: licensing agreements, collaboration agreements, confidentiality agreements and material transfer agreements
- client counseling: patent application and claim drafting counseling, prosecution strategies, related life-cycle management, foreign filing strategy and trade secret protection
- patent procurement: patent drafting and prosecution, patentability assessment, reissues, reexaminations and appeals before the USPTO
- due diligence: ownership and inventorship investigations, portfolio analysis, and freedom-to-operate and validity searches, analyses and opinions
- post-grant procedures: patent term extension, interference and litigation support